We are monitoring the impact of COVID-19 on Asia Pacific Active Implantable Medical Devices Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4853
Share on
Share on

Asia Pacific Active Implantable Medical Devices Market Research Report – Segmented By Product & By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Growth, Trends, Forecast | 2019 - 2024

Pulished: February, 2020
ID: 4853
Pages: 145

Asia Pacific Active Implantable Medical Devices Market Size & Growth (2019 – 2024):

The size of the APAC Active Implantable Medical Devices Market is anticipated to grow at 8.45% CAGR from 2019 to 2024 and it is estimated that the Asia-Pacific market is valued at USD 4.28 billion in 2019 and is expected to reach USD 6.43 billion by 2024 during the forecast period 2019-2024.

The Active Implantable Medical Device (AIMD) Directive 90/385/EEC defines an active implantable medical device as "any active medical device which is intended to be totally or partially introduced, surgically or medically, into the human body or by medical intervention into a natural orifice, and which is intended to remain after the procedure". As one of the highest risk categories of device, they are subject to severe regulatory controls both pre- and post-market. The regulatory controls set out in the AIMD Directive also apply to any accessories that are used to enable the device to operate as intended, for example, leads, programmers, controllers, battery packs, software applications, implant kits, and refill kits. 

According to the World Health Organization WHO, globally, around 17.5 million people died due to cardiovascular diseases in 2012, while the number is anticipated to reach 23.3 million by 2030. Factors such as advancement in technological, increase in the prevalence of cardiovascular diseases, rise in the healthcare expenditures by patients and increase in the research and development activities are the major factors driving the growth of the global active implantable medical devices market. However, the high cost of implantable medical devices and unfavourable reimbursement guidelines pose a crucial challenge thereby limiting the adoption of active implantable medical devices solutions.

The demand for active implantable medical devices is rising due to an increase in the prevalence of cardiovascular diseases and an increase in the incidence of neurological disorders. Cardiovascular disease is the leading cause of premature death around the world. Implantable cardioverter defibrillators and implantable cardiac pacemakers are the main medical devices used for the treatment of different cardiovascular conditions. The high prevalence of cardiovascular diseases depicts an increase in the demand for these devices.

Asia Pacific Active Implantable Medical Devices Market segmented and sub-segmented into the following categories.

  • By Product: Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices).
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

On the basis of region, the market in the Asia-Pacific region is expected to grow at the highest CAGR, due to the rise in geriatric population, growth in the occurrence of chronic diseases, rise in healthcare spending, healthcare reforms for infrastructural development, growth in the demand for advanced technologies to develop advanced products, and less strict regulations.

The countries such as China and India have a large geriatric population and the healthcare infrastructure in these countries is improving, thus illustrating immense healthcare market potential.

Some of the Promising companies leading the Asia Pacific Active Implantable Medical Devices Market Profiled in the Report are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC., Cochlear Limited, MED-EL, Sonova Holding AG, William Demant Holding A/S, and Nurotron Biotechnology Co. Ltd

 

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Implantable Cardioverter Defibrillators                      

                                                5.1.2.1 Transvenous Implantable Cardioverter Defibrillators        

                                                                5.1.2.1.1 Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)

                                                                5.1.2.1.2 Dual-Chamber Implantable Cardioverter Defibrillators

                                                                5.1.2.1.3 Single-Chamber Implantable Cardioverter Defibrillators

                                                5.1.2.2 Subcutaneous Implantable Cardioverter Defibrillator       

                                5.1.3 Implantable Cardiac Pacemakers                   

                                5.1.4 Ventricular Assist Devices                 

                                5.1.5 Implantable Heart Monitors/Insertable Loop Recorders                     

                                5.1.6 Neurostimulators                 

                                                5.1.6.1 Spinal Cord Stimulators  

                                                5.1.6.2 Deep Brain Stimulators  

                                                5.1.6.3 Sacral Nerve Stimulators               

                                                5.1.6.4 Vagus Nerve Stimulators               

                                                5.1.6.5 Gastric Electrical Stimulators        

                                5.1.7 Implantable Hearing Devices                           

                                                5.1.7.1 Active Hearing Implants 

                                                5.1.7.2 Passive Hearing Implants              

                                5.1.5  Y-o-Y Growth Analysis, By Product                              

                                5.1.6  Market Attractiveness Analysis, By Product                            

                                5.1.7  Market Share Analysis, By Product                              

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                6.2 China                                             

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                                               

                6.6 Australia                                      

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Medtronic plc                                            

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Abbott Laboratories                                               

                8.3 Boston Scientific Corporation                                             

                8.4 BIOTRONIK SE & Co. KG                                        

                8.5 LivaNova PLC.                                            

                8.6 Cochlear Limited                                      

                8.7 MED-EL                                        

                8.8 Sonova Holding AG                                 

                8.9 William Demant Holding A/S                                               

                8.10 Nurotron Biotechnology Co. Ltd.                                    

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the region-wise market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  2. Asia-Pacific Implantable Cardioverter Defibrillators Market By Region, From 2019-2024 ( USD Billion )
  3. Asia-Pacific Cardiac Pacemaker Market By Region, From 2019-2024 ( USD Billion )
  4. Asia-Pacific Ventricular Assist Device Market By Region, From 2019-2024 ( USD Billion )
  5. Asia-Pacific Neurostimulator Market By Region, From 2019-2024 ( USD Billion )
  6. Asia-Pacific Implantable Hearing Devices Market By Region, From 2019-2024 ( USD Billion )
  7. Japan Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  8. China Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  9. India Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  10. Australia Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )
  11. South Korea Active Implantable Medical Devices  Market By Product, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample